Enigma Diagnostics Limited

📍 Salisbury, United Kingdom🗓 Founded 2004👥 10 employees💰 Last funded 2004
The world’s first Point-of-Care Highly Multiplex PCR MiniLab Platform empowers clinicians with 24/7 access to fast comprehensive actionable laboratory-quality molecular diagnostic results for the simultaneous in vitro diagnostic detection a range of targets reducing test result waiting times to about an hour. It is well documented that a fast accurate diagnosis and targeted treatment improves clinical outcomes while reducing costs and supports good antimicrobial stewardship. The MiniLab is designed to support the clinical sample collection workflow by minimizing pipetting steps as well allowing the lab to “push” its services out to decentralized labs. Built in QC features allow the lab to control the use of the platform and data integration allows the transfer of results. The easy-to-use sample-to-results MiniLab features a fully integrated Control Module that commands up to six fully automated Processing Modules making the MiniLab’s architecture scalable. The Processing Modules can run different panels with independent random access.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2004
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Enigma Diagnostics Limited?
Enigma Diagnostics Limited has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Enigma Diagnostics Limited last raise funding?
The most recent investment in Enigma Diagnostics Limited recorded on gritt.io was in 2004.
When was Enigma Diagnostics Limited founded?
Enigma Diagnostics Limited was founded in 2004.
What industry is Enigma Diagnostics Limited in?
Enigma Diagnostics Limited operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is Enigma Diagnostics Limited based?
Enigma Diagnostics Limited is headquartered in Salisbury, United Kingdom.